top of page
Search
  • Writer's pictureHarun Mugambi

Russia Close to Creating Effective Cancer Vaccines, Putin Announces

In a significant announcement, President Vladimir Putin declared that Russian scientists are on the brink of creating effective cancer vaccines on Wednesday 14.


The statement was made during a televised press conference at a Moscow forum on future technologies. According to Reuters Putin said in televised comments that "we have come very close to the creation of so-called cancer vaccines and immunomodulatory drugs of a new generation"


A New Generation of Drugs


Putin stated that the country has come very close to the creation of so-called cancer vaccines and immunomodulatory drugs of a new generation. According to Reuters he said, "I hope that soon they will be effectively used as methods of individual therapy." He also expressed hope that these vaccines would soon be effectively used as methods of individual therapy. However, he did not specify which types of cancer the proposed vaccines would target.


Global Efforts in Cancer Vaccines


The announcement comes at a time when several countries and companies are working on cancer vaccines. A number of countries and companies are working on cancer vaccines. Last year the UK government signed an agreement with Germany-based BioNTech to launch clinical trials providing "personalised cancer treatments", aiming to reach 10,000 patients by 2030. Pharmaceutical

Existing Vaccines


Currently, there are six licensed vaccines against human papillomaviruses (HPV) that cause many cancers, including cervical cancer, according to the World Health Organization, as well as vaccines against hepatitis B (HBV), which can lead to liver cancer.


Russia's Track Record in Vaccine Development


During the coronavirus pandemic, Russia developed its own Sputnik V vaccine against COVID-19 and sold it to a number of countries. However, it faced widespread public reluctance to get vaccinated domestically. Putin himself said he had taken Sputnik, in a bid to assure people of its efficacy and safety.

Comments


bottom of page